You just read:

Grünenthal, Boston Children's Hospital and Proteus S.A. Announce a Partnership and Development Program for Neosaxitoxin

News provided by

Gruenenthal Pharma GmbH & Co. KG

12 Jun, 2015, 17:15 BST